 | • レポートコード：MRC2-11QY05033 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウイルス分子診断のグローバル市場について調査・分析したレポートです。種類別（B型肝炎ウイルス（HBV）、C型肝炎ウイルス（HCV）、ヒト免疫不全ウイルス（HIV）、ヒトパピローマウイルス（HPV））市場規模、用途別（病院、学術機関、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウイルス分子診断の競争状況、市場シェア ・世界のウイルス分子診断市場：種類別市場規模 2015年-2020年（B型肝炎ウイルス（HBV）、C型肝炎ウイルス（HCV）、ヒト免疫不全ウイルス（HIV）、ヒトパピローマウイルス（HPV）） ・世界のウイルス分子診断市場：種類別市場規模予測 2021年-2026年（B型肝炎ウイルス（HBV）、C型肝炎ウイルス（HCV）、ヒト免疫不全ウイルス（HIV）、ヒトパピローマウイルス（HPV）） ・世界のウイルス分子診断市場：用途別市場規模 2015年-2020年（病院、学術機関、研究所、その他） ・世界のウイルス分子診断市場：用途別市場規模予測 2021年-2026年（病院、学術機関、研究所、その他） ・北米のウイルス分子診断市場分析：米国、カナダ ・ヨーロッパのウイルス分子診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウイルス分子診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウイルス分子診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウイルス分子診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboraories、Bio-Rad Laboratories、Becton, Dickinson、Roche、Gen-Probe、Qiagen、Olympus、Thermo Fisher Scientific ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases in this region.
Market Analysis and Insights: Global Viral Molecular Diagnostics Market
The global Viral Molecular Diagnostics market size is projected to reach US$ 8622.1 million by 2026, from US$ 8000 million in 2020, at a CAGR of 7.2%% during 2021-2026.
Global Viral Molecular Diagnostics Scope and Market Size
Viral Molecular Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Market segment by Application, split into
Hospitals
Academics Institutions
Laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Molecular Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hepatitis B Virus (HBV)
1.4.3 Hepatitis C Virus (HCV)
1.4.4 Human Immunodeficiency Virus (HIV)
1.4.5 Human Papillomavirus (HPV)
1.5 Market by Application
1.5.1 Global Viral Molecular Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Academics Institutions
1.5.4 Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Viral Molecular Diagnostics Market Perspective (2015-2026)
2.2 Global Viral Molecular Diagnostics Growth Trends by Regions
2.2.1 Viral Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Molecular Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Viral Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Molecular Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Molecular Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Molecular Diagnostics Players by Market Size
3.1.1 Global Top Viral Molecular Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Molecular Diagnostics Market Concentration Ratio
3.2.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2019
3.3 Viral Molecular Diagnostics Key Players Head office and Area Served
3.4 Key Players Viral Molecular Diagnostics Product Solution and Service
3.5 Date of Enter into Viral Molecular Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Viral Molecular Diagnostics Market Size by Application (2015-2020)
5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Molecular Diagnostics Market Size (2015-2020)
6.2 Viral Molecular Diagnostics Key Players in North America (2019-2020)
6.3 North America Viral Molecular Diagnostics Market Size by Type (2015-2020)
6.4 North America Viral Molecular Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Molecular Diagnostics Market Size (2015-2020)
7.2 Viral Molecular Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Viral Molecular Diagnostics Market Size by Type (2015-2020)
7.4 Europe Viral Molecular Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Viral Molecular Diagnostics Market Size (2015-2020)
8.2 Viral Molecular Diagnostics Key Players in China (2019-2020)
8.3 China Viral Molecular Diagnostics Market Size by Type (2015-2020)
8.4 China Viral Molecular Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Molecular Diagnostics Market Size (2015-2020)
9.2 Viral Molecular Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Viral Molecular Diagnostics Market Size by Type (2015-2020)
9.4 Japan Viral Molecular Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Molecular Diagnostics Market Size (2015-2020)
10.2 Viral Molecular Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Molecular Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Molecular Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Viral Molecular Diagnostics Market Size (2015-2020)
11.2 Viral Molecular Diagnostics Key Players in India (2019-2020)
11.3 India Viral Molecular Diagnostics Market Size by Type (2015-2020)
11.4 India Viral Molecular Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Molecular Diagnostics Market Size (2015-2020)
12.2 Viral Molecular Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Molecular Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Viral Molecular Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboraories
13.1.1 Abbott Laboraories Company Details
13.1.2 Abbott Laboraories Business Overview
13.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
13.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2015-2020))
13.1.5 Abbott Laboraories Recent Development
13.2 Bio-Rad Laboratories
13.2.1 Bio-Rad Laboratories Company Details
13.2.2 Bio-Rad Laboratories Business Overview
13.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
13.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.2.5 Bio-Rad Laboratories Recent Development
13.3 Becton, Dickinson
13.3.1 Becton, Dickinson Company Details
13.3.2 Becton, Dickinson Business Overview
13.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
13.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.3.5 Becton, Dickinson Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Viral Molecular Diagnostics Introduction
13.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Gen-Probe
13.5.1 Gen-Probe Company Details
13.5.2 Gen-Probe Business Overview
13.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
13.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.5.5 Gen-Probe Recent Development
13.6 Qiagen
13.6.1 Qiagen Company Details
13.6.2 Qiagen Business Overview
13.6.3 Qiagen Viral Molecular Diagnostics Introduction
13.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.6.5 Qiagen Recent Development
13.7 Olympus
13.7.1 Olympus Company Details
13.7.2 Olympus Business Overview
13.7.3 Olympus Viral Molecular Diagnostics Introduction
13.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.7.5 Olympus Recent Development
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Details
13.8.2 Thermo Fisher Scientific Business Overview
13.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
13.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2015-2020)
13.8.5 Thermo Fisher Scientific Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Viral Molecular Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Molecular Diagnostics Revenue
Table 3. Ranking of Global Top Viral Molecular Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hepatitis B Virus (HBV)
Table 6. Key Players of Hepatitis C Virus (HCV)
Table 7. Key Players of Human Immunodeficiency Virus (HIV)
Table 8. Key Players of Human Papillomavirus (HPV)
Table 9. Global Viral Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Viral Molecular Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Viral Molecular Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Viral Molecular Diagnostics Market Share by Regions (2015-2020)
Table 13. Global Viral Molecular Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Viral Molecular Diagnostics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Viral Molecular Diagnostics Market Growth Strategy
Table 19. Main Points Interviewed from Key Viral Molecular Diagnostics Players
Table 20. Global Viral Molecular Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Viral Molecular Diagnostics Market Share by Players (2015-2020)
Table 22. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Molecular Diagnostics as of 2019)
Table 23. Global Viral Molecular Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Viral Molecular Diagnostics Product Solution and Service
Table 26. Date of Enter into Viral Molecular Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Viral Molecular Diagnostics Market Size Share by Type (2015-2020)
Table 30. Global Viral Molecular Diagnostics Revenue Market Share by Type (2021-2026)
Table 31. Global Viral Molecular Diagnostics Market Size Share by Application (2015-2020)
Table 32. Global Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Viral Molecular Diagnostics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 36. North America Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 38. North America Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 42. Europe Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 44. Europe Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 46. China Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 48. China Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 49. China Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 50. China Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 51. China Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 54. Japan Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 56. Japan Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 60. Southeast Asia Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 62. Southeast Asia Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 64. India Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 66. India Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 67. India Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 68. India Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 69. India Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Viral Molecular Diagnostics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Viral Molecular Diagnostics Market Share (2019-2020)
Table 72. Central & South America Viral Molecular Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Viral Molecular Diagnostics Market Share by Type (2015-2020)
Table 74. Central & South America Viral Molecular Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Viral Molecular Diagnostics Market Share by Application (2015-2020)
Table 76. Abbott Laboraories Company Details
Table 77. Abbott Laboraories Business Overview
Table 78. Abbott Laboraories Product
Table 79. Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 80. Abbott Laboraories Recent Development
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories Product
Table 84. Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 85. Bio-Rad Laboratories Recent Development
Table 86. Becton, Dickinson Company Details
Table 87. Becton, Dickinson Business Overview
Table 88. Becton, Dickinson Product
Table 89. Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 90. Becton, Dickinson Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Product
Table 94. Roche Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 95. Roche Recent Development
Table 96. Gen-Probe Company Details
Table 97. Gen-Probe Business Overview
Table 98. Gen-Probe Product
Table 99. Gen-Probe Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 100. Gen-Probe Recent Development
Table 101. Qiagen Company Details
Table 102. Qiagen Business Overview
Table 103. Qiagen Product
Table 104. Qiagen Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 105. Qiagen Recent Development
Table 106. Olympus Company Details
Table 107. Olympus Business Overview
Table 108. Olympus Product
Table 109. Olympus Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 110. Olympus Recent Development
Table 111. Thermo Fisher Scientific Business Overview
Table 112. Thermo Fisher Scientific Product
Table 113. Thermo Fisher Scientific Company Details
Table 114. Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2015-2020) (Million US$)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Molecular Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Hepatitis B Virus (HBV) Features
Figure 3. Hepatitis C Virus (HCV) Features
Figure 4. Human Immunodeficiency Virus (HIV) Features
Figure 5. Human Papillomavirus (HPV) Features
Figure 6. Global Viral Molecular Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Academics Institutions Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Molecular Diagnostics Report Years Considered
Figure 12. Global Viral Molecular Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Viral Molecular Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Viral Molecular Diagnostics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Viral Molecular Diagnostics Market Share by Players in 2019
Figure 17. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Molecular Diagnostics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Viral Molecular Diagnostics Revenue in 2019
Figure 19. North America Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Viral Molecular Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…- ヒト免疫不全ウイルス（HIV）の世界市場（～2026年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…
- ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…
- ヒトパピローマウイルス（HPV）検査の世界市場（～2026年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
- ウイルス性肝炎・レトロウイルス診断検査の世界市場（～2026年） Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patien…